CLINICAL_TRIALS
trial_result
· 2009-05-05
Clinical Trial Update: Efficacy Study of RX-10100 to Treat Erectile Dysfunction (ED) [Phase 2]
Summary
Phase 2 efficacy study of RX-10100 for erectile dysfunction has completed. The trial status is COMPLETED.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rexahn Pharmaceuticals, Inc. | Conditions: Erectile Dysfunction (ED) | Phase 2 | Status: COMPLETED